iiinova — where your digital self keeps evolving

Reposted by Drew Armstrong

Endpoints News @endpts.com · 13/05/2025

Join us at 1130am ET today for our latest Post-Hoc Live stream, to talk about Trump's "most favored nation" drug price plan. Executive editor @drewsnews.bsky.social and Nick Shipley talk about how the executive order works (or doesn't) and what happens next. www.youtube.com/live/7qGP5Ge...

youtube.com

"Most Favored Nation": The White House plan to cut drug prices

YouTube video by Endpoints News

111

Drew Armstrong @drewsnews.bsky.social · 13/05/2025

I've been trying to do this chat for YEARS and am so glad we are finally making it happen. Come for the health policy, stay for the GameStop story.

010

Reposted by Drew Armstrong

Lizzie O'Leary @lizzieohreally.bsky.social · 13/05/2025

If you are going to the FT Pharma and Biotech summit on Thursday, please come drop by my session where I'll be chatting with @drewsnews.bsky.social about my lil cancer, and some other fun things. uspharma.live.ft.com/agenda

041

Reposted by Drew Armstrong

Dan Diamond @ddiamond.bsky.social · 26/02/2025

Elon Musk said DOGE made a mistake by cutting USAID’s Ebola prevention but it had been “restored.” That’s not true, current and former officials told me and @johnphudson.bsky.social. “There have been no efforts to ‘turn on’” Ebola prevention, said Nidhi Bouri, who oversaw team until January.

washingtonpost.com

Musk claims DOGE ‘restored’ Ebola prevention effort. Officials disagree.

USAID’s initiatives to fight Ebola and other diseases have been gutted, current and former agency officials said.

23074393157

Reposted by Drew Armstrong

Michael Gilman @gilman.bsky.social · 27/02/2025

Kudos to the @endpts.com team for not running away from this issue like everyone else.

0275

Reposted by Drew Armstrong

Derek Lowe @dereklowe.bsky.social · 14/02/2025

Well, as I said a couple of weeks ago, thank God I'm not a CEO and I don't have to do this sort of dirty work. Because let's not kid around: if it has to do with the intersection of business and the Trump administration as it's been running so far, it's going to end up being dirty.

endpts.com

Exclusive: Drugmakers plan Trump meeting next week amid Washington health shakeups

Major drugmakers are planning to meet with President Donald Trump next week at the White House as part of the industry’s effort to work with the new administration.

0308

Drew Armstrong @drewsnews.bsky.social · 28/01/2025

🏈📺This Hims Super Bowl ad leans very hard into the "pharma bad" / MAHA angle. Looks like these guy are picking a fight (in part over compounding, but swinging bigger than that) with pharma: www.youtube.com/watch?v=l5l6...

t.co

https://www.youtube.com/watch?v=l5l6QMNnqoc

121

Drew Armstrong @drewsnews.bsky.social · 06/01/2025

We're a week out from Endpoints News at #JPM2025, and the agenda is fantastic! We'll talk through the Trump transition, AI's year ahead, John Carrol will lead chats on cancer and dealmaking, and more. If you don't have a ticket, I've got a discount 😉> JPM25_10 events.endpts.com/jpm25/697639...

events.endpts.com

Endpoints at #JPM25 - January 13-14, 2025 - San Francisco

In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM.

042

Drew Armstrong @drewsnews.bsky.social · 19/12/2024

...Pain trials are hard (so is anything w/ patient self-scoring) ...And placebo problems are real ...But this is a result that could kill a program or even a company at little biotech. (Vertex has the $$ + rep for Ph3 to find out if they're right.) endpts.com/vertexs-non-...

endpts.com

Vertex’s non-opioid pill disappoints in mid-stage chronic pain study

Vertex Pharmaceuticals announced highly anticipated results from a Phase 2 trial Thursday morning in a chronic pain condition, saying its non-opioid pain pill suzetrigine met the primary endpoint and ...

231

Drew Armstrong @drewsnews.bsky.social · 18/12/2024

The @endpts.com JPM agenda is LIVE. This is going to be next-level. We've got Jennifer Doudna, Scott Gottlieb, Hal Barron, Eric Tokat, Janet Woodcock, Steve Hahn and many, MANY more huge names... events.endpts.com/jpm25/agenda

events.endpts.com

Agenda

042

Reposted by Drew Armstrong

Max Bayer @maxbayer.bsky.social · 17/12/2024

If you're an @endpts.com subscriber, you may have recently seen a note in your inbox from @drewsnews.bsky.social. The TLDR is that many of us are here, on this site, giving you the biopharma and health care news you need. Give us a follow! Give us feedback! I always want to hear how we can improve.

0102

Reposted by Drew Armstrong

Endpoints News @endpts.com · 17/12/2024

Just finding us here? Endpoints News has a starter pack with our journalists so you can follow the team! go.bsky.app/NzDRUhL

2206

Drew Armstrong @drewsnews.bsky.social · 11/12/2024

I wrote about covering a shooting a 13 years ago, how the medium of the moment distorts violence in strange ways, and the strange, worrying moment we're in with the killing of an insurance executive. endpts.com/post-hoc-wha...

142

Drew Armstrong @drewsnews.bsky.social · 04/12/2024

A great follow on rare disease, diagnostics and cool tech:

031

Drew Armstrong @drewsnews.bsky.social · 04/12/2024

UnitedHealth has confirmed the shooting and death of insurance group head Brian Thompson in Manhattan this morning. They've (obviously) canceled investor day. Completely shocking. endpts.com/ceo-of-unite...

endpts.com

CEO of UnitedHealth insurance unit shot and killed in New York

UnitedHealthcare CEO Brian Thompson was shot and killed in Midtown Manhattan on Wednesday morning, according to media reports.

013

Drew Armstrong @drewsnews.bsky.social · 04/12/2024

Lilly released it's head-to-head with Wegovy today and it appears to have a meaningful edge on long-term weight loss (handy chart from Liz Cairns)

122

Drew Armstrong @drewsnews.bsky.social · 03/12/2024

And... we've got an Endpoints News starter pack! Join up! go.bsky.app/NzDRUhL

go.bsky.app

Endpoints News Starter Pack

Join the conversation

164

Drew Armstrong @drewsnews.bsky.social · 03/12/2024

This is the furthest @scottgottliebmd.bsky.social tt (who ran the FDA during Trump 1.0) has gone in criticizing Trump's pick for HHS.

121

Reposted by Drew Armstrong

Endpoints News @endpts.com · 03/12/2024

Former FDA Commissioner Scott Gottlieb opposed President-elect Donald Trump’s choice to lead the Department of Health and Human Services, saying RFK Jr.’s policies would lead to a resurgence of preventable diseases and cost lives, @drewsnews.bsky.social reports. endpts.com/former-fda-h...

endpts.com

Scott Gottlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this country’

Former FDA commissioner Scott Gottlieb came out against president-elect Trump’s choice of Robert F. Kennedy Jr. to lead the Department of Health and Human Services, saying his policies would lead to a...

022

Drew Armstrong @drewsnews.bsky.social · 30/11/2024

🟨😎🟦 AAHAHAHHAHAHAHAHAHAHAHAHAHAHAHAH

020

Drew Armstrong @drewsnews.bsky.social · 27/11/2024

Loved this Odd Lots from @tracyalloway.bsky.social + @weisenthal.bsky.social on Medicare fraud. A great primer for anyone interested in govt fraud/abuse, with a nice dose of DME, dialysis + ambulance shenanigans. podcasts.apple.com/us/podcast/h...

podcasts.apple.com

How Fraudsters Are Bilking the Government Out of Billions of Dollars

Podcast Episode · Odd Lots · 11/18/2024 · 45m

1256

Drew Armstrong @drewsnews.bsky.social · 23/11/2024

👀Warp speed mention in surgeon general announcement...

130

Reposted by Drew Armstrong

Dan Diamond @ddiamond.bsky.social · 22/11/2024

Breaking: Florida's top health official calls for an end to fluoride in state's drinking water. Joseph Ladapo, Florida's surgeon general who has been bidding for a spot in Trump admin, cites controversial studies about the risk of fluoride to developing brains. w @fenitn.bsky.social

washingtonpost.com

Florida surgeon general calls for halting fluoride in water, echoing RFK Jr

The state’s top health official cited controversial studies that suggest the widely hailed public health practice poses a risk to developing brains.

6816959

Reposted by Drew Armstrong

Alice Miranda Ollstein @alicemiranda.bsky.social · 22/11/2024

NEW w/ @adamcancryn.bsky.social: At least 3 antivax activists are helping RFK Jr. recruit and vet candidates for top jobs at HHS. While the Trump transition argues they're not part of the official process, they're calling themselves the 'MAHA transition team.' www.politico.com/news/2024/11...

politico.com

Kennedy's 'MAHA transition team' includes anti-vax activists

At least three informal advisers connected to the anti-vaccine movement are assisting Kennedy in filling out his staff as he prepares to lead HHS.

1010573

Drew Armstrong @drewsnews.bsky.social · 22/11/2024

Really interesting story about how chemistry + law affect markets: Eli Lilly is trying to get its next weigth-loss drug classified as a biologic. Why? To avoid the threat of compounding pharmacies. The crux of the case is a single amino acid: endpts.com/drug-or-biol...

endpts.com

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of popular weight loss and diabetes drugs. A new legal strategy could put Lilly one...

110

Drew Armstrong @drewsnews.bsky.social · 21/11/2024

I for one am glad that every journalist who did their time writing the once-every-five-years RUC explainer might finally get their moment in the sun.

010

Reposted by Drew Armstrong

Pearl Freier @pearlf.bsky.social · 20/11/2024

A starter pack of biotech founders curated by Jason Kelly— the co-founder and CEO of Ginkgo Bioworks #biosky

081

Drew Armstrong @drewsnews.bsky.social · 20/11/2024

Hi new followers. I'm Drew Armstrong, the Executive Editor of Endpoints News (endpts.com). I post about biotech, pharma, VC, science, markets + healthcare policy.

endpts.com

Endpoints News

Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

2262

Drew Armstrong @drewsnews.bsky.social · 20/11/2024

It looks like Sage's last big neuro bet has failed. The company is now trading for less than the cash on its books. It has no other midstage or advanced programs in the works. endpts.com/sage-reports...

endpts.com

Updated: Sage reports Phase 2 failure in Huntington's disease, ends drug's development

Sage’s final hope to turn its business around has failed, leaving the future of the once high-flying company and its postpartum depression drug uncertain.

120

Drew Armstrong @drewsnews.bsky.social · 19/11/2024

Interesting piece from @scottgottliebmd.bsky.social on the GLP-1 compounding debate. I'm not sure how you put this back in the bottle -- big market, major cost debate. Feels like a one-way street...

141

Reposted by Drew Armstrong

Theo Sanderson @theo.io · 12/11/2024

My app for finding 🦋 accounts you may want to follow has had a make-over: it now displays names and bios, and allows adding an "app password" for direct follow buttons in the listing bsky-follow-finder.theo.io

bsky-follow-finder.theo.io

Bluesky Network Analyzer

Find accounts that you don't follow (yet) but are followed by lots of accounts that you do follow.

96614260

Drew Armstrong @drewsnews.bsky.social · 19/11/2024

Some very interesting names in this @politico.com report on possible Trump admin health picks: * The Means siblings in senior roles (Casey potential Surgeon Gen, Calley in a top deputy role -- but neither at FDA) * CDC, NIH possibles www.politico.com/news/2024/11...

politico.com

Trump transition closes in on picks for top health posts

Many of the candidates are allies of RFK Jr. and have maligned the agencies they would oversee.

133

Reposted by Drew Armstrong

Calin Plesa @calin.bsky.social · 12/11/2024

Started creating a synthetic biology starter pack. Still missing many so reply here if I forgot you or someone else. go.bsky.app/SjfpxTK #synbio

709546

Drew Armstrong @drewsnews.bsky.social · 19/11/2024

📣This is always VERY interesting. If you're a biopharma CEO (public or private) and want to be included, DM me. We are working on a few exclusive benefits for respondents.

010